AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 78 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 13.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $43,000 | -51.7% | 26,777 | -0.4% | 0.00% | – |
| Q3 2018 | $89,000 | +17.1% | 26,896 | -20.1% | 0.00% | – |
| Q2 2018 | $76,000 | +111.1% | 33,652 | +73.4% | 0.00% | – |
| Q4 2013 | $36,000 | -2.7% | 19,410 | +7.6% | 0.00% | – |
| Q3 2013 | $37,000 | -9.8% | 18,044 | +10.3% | 0.00% | – |
| Q2 2013 | $41,000 | – | 16,354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 25,243,865 | $16,913,000 | 1.18% |
| SABBY MANAGEMENT, LLC | 281,112 | $189,000 | 0.24% |
| New Leaf Venture Partners, L.L.C. | 402,118 | $271,000 | 0.07% |
| WealthTrust Axiom LLC | 134,585 | $90,000 | 0.03% |
| EXCALIBUR MANAGEMENT CORP | 51,000 | $34,000 | 0.03% |
| Caption Management, LLC | 748,200 | $503,000 | 0.02% |
| Anson Funds Management LP | 98,986 | $66,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 210,474 | $142,000 | 0.02% |
| Evercore Wealth Management, LLC | 418,414 | $282,000 | 0.01% |
| Gemmer Asset Management LLC | 1,939 | $31,000 | 0.01% |